Davies, Nicholas G; Abbott, Sam; Barnard, Rosanna C; Jarvis, Christopher I; Kucharski, Adam J; Munday, James D; Pearson, Carl AB; Russell, Timothy W; Tully, Damien C; Washburne, Alex D; +15 more... Wenseleers, Tom; Gimma, Amy; Waites, William; Wong, Kerry LM; van Zandvoort, Kevin; Silverman, Justin D; CMMID COVID-19 Working Group; COVID-19 Genomics UK (COG-UK) Consortium; Diaz-Ordaz, Karla; Keogh, Ruth; Eggo, Rosalind M; Funk, Sebastian; Jit, Mark; Atkins, Katherine E; Edmunds, W John; (2021) Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science (New York, N.Y.), 372 (6538). 149-+. ISSN 0036-8075 DOI: https://doi.org/10.1126/science.abg3055
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Abstract
A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, VOC 202012/01 (lineage B.1.1.7), emerged in southeast England in September 2020 and is rapidly spreading toward fixation. Using a variety of statistical and dynamic modeling approaches, we estimate that this variant has a 43 to 90% (range of 95% credible intervals, 38 to 130%) higher reproduction number than preexisting variants. A fitted two-strain dynamic transmission model shows that VOC 202012/01 will lead to large resurgences of COVID-19 cases. Without stringent control measures, including limited closure of educational institutions and a greatly accelerated vaccine rollout, COVID-19 hospitalizations and deaths across England in the first 6 months of 2021 were projected to exceed those in 2020. VOC 202012/01 has spread globally and exhibits a similar transmission increase (59 to 74%) in Denmark, Switzerland, and the United States.
Download
Filename: preprint.pdf
Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0
Download